The Law Library of Congress recently published its report, Pharmaceutical Antitrust Cases, which provides a comparative analysis of antitrust and competition cases concerning the pharmaceutical industry in 12 jurisdictions. The jurisdictions covered by this report include Australia, Denmark, the European Union, France, India, Israel, Japan, the Netherlands, South Korea, Spain, Taiwan, and the United Kingdom. The report also provides information on the competition law frameworks and enforcement agencies in Canada, Germany, New Zealand, Norway, Singapore, Switzerland, and Sweden.
The report begins with a comparative summary providing an overview of pharmaceutical antitrust litigation in the selected jurisdictions and then proceeds to a multinational description of recent cases. The case summaries include the anti-competitive behavior that was alleged, the company or companies in question, the judicial proceedings conducted, and the eventual sanction or fine issued to the companies. In jurisdictions without reported cases, the appendix to the report provides information on the legislative or administrative processes in place to prevent anti-competitive behavior, as well as information on the relevant enforcement agencies of the jurisdiction.
This report is an addition to the Law Library’s Legal Reports (Publications of the Law Library of Congress) collection, which includes over 3,000 historical and contemporary legal reports covering a variety of jurisdictions, researched and written by foreign legal specialists with expertise in each area.
Subscribe to In Custodia Legis – it’s free! – to receive interesting posts drawn from the Law Library of Congress’s vast collections and our staff’s expertise in U.S., foreign, and international law.